AbbVie Raises FY26 Adjusted EPS Outlook; Boosts Dividend 5.2%
AbbVie raised its adjusted earnings guidance for full-year 2026 while reporting third-quarter results. It also boosted its dividend by 5.2%.
Story updates
12:36:52 PM UTC
SquawkNews
08:36 AM EDT, 10/30/2026 (MT Newswires) -- (Updates to add details on dividend in the sixth paragrap
WASHINGTON (dpa-AFX) - While reporting financial results for the third quarter on Friday, biopharmaceutical company AbbVie, Inc. (ABBV) raised its adjusted earnings guidance for the full-year 2026, based on strong outlook and significant momentum.For fiscal 2026, AbbVie now projects adjusted earnin…